" />
Glucose 30M post dose arginine insulin:MCnc:Pt:Ser/Plas:Qn: - CISMeF
Glucose 30M post dose arginine insulin:MCnc:Pt:Ser/Plas:Qn:LOINC code
Preferred Label : Glucose 30M post dose arginine insulin:MCnc:Pt:Ser/Plas:Qn:;
LOINC status : ACTIVE;
LOINC display name : Glucose 30 Min post dose arginine insulin [Mass/Vol];
LOINC long common name : Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose arginine insulin;
LOINC short name : Glucose 30M p Arg Ins SerPl-mCnc;
LOINC description : This test is part of one growth hormone deficiency testing procedure, in which glucose
and growth hormone levels are measured at specific time intervals after the administration
of arginine and insulin. Normally, arginine and insulin-induced hypoglycemia stimulate
the release of growth hormone, so patients without growth hormone deficiency will
have a significant increase in serum growth hormone in response to arginine and insulin
administration. In patients with growth hormone deficiency, however, the increase
in and the absolute peak of the growth hormone level will be much lower than expected.
Glucose levels are monitored during this procedure because a certain level of hypoglycemia
has to be achieved in order to stimulate growth hormone release, and periodic glucose
measurements can be used to titrate the insulin dose as needed.;
Has challenge